On Cancer

and/or

115 Blog posts found

Q & A

Meet Chronic Lymphocytic Leukemia Expert Anthony Mato

Meet hematologic oncologist Anthony Mato and learn why people who have been diagnosed with chronic lymphocytic leukemia should come to MSK.

Hematologic oncologist Anthony Mato

Feature

Meet This Year's Stop & Shop Ambassadors for Pediatric Cancer Research

Meet the four young ambassadors featured in the annual Stop & Shop campaign to fundraise for the Department of Pediatrics at Memorial Sloan Kettering.

Young girl wearing pink sits with her mother

Roundup

Highlights from ASCO 2018: Immunotherapy for Endometrial Cancer, Benefits of Exercise, and Promising New Targeted Drugs

Couldn't make it to the American Society of Clinical Oncology's annual meeting this year? Read this summary of some main takeaways.

Crowded hall with ASCO signage

Q & A

Some Women with Early Breast Cancer May Not Need Chemotherapy, Study Says

Learn about the results of a trial showing that women with intermediate-risk breast cancer may not need chemotherapy.

medical oncologist Larry Norton

Finding

Targeted Therapy Slows Growth of Most Common Type of Advanced Breast Cancer

A clinical trial provides evidence that blocking a protein called PI3K can be an effective treatment strategy for breast cancer.

MSK Physician-in-Chief José Baselga presents at the ASCO meeting

In the Clinic

Immunotherapy Combination Is Better than Chemotherapy for Non-Small Cell Lung Cancer

MSK’s Matthew Hellmann led an international, phase III trial looking at the combination of immunotherapy drugs ipilimumab and nivolumab.

MSK medical oncologist Matthew Hellmann

Finding

Immunotherapy Combination Offers a Better Chance at Longer Survival for Patients with Metastatic Kidney Cancer

Learn about how the immunotherapies ipilimumab (Yervoy®) and nivolumab (Opdivo®) could provide a new option for patients with metastatic renal cell carcinoma.

MSK medical oncologist Robert Motzer

In the Clinic

Immunotherapy Drug Shows Promise for Metastatic Merkel Cell Carcinoma

An immunotherapy drug might be an effective initial treatment for people with metastatic Merkel cell carcinoma.

Dermatologist examining skin on the face of older man.

Feature

The New Age of Colorectal Cancer: People under 50

Doctors are troubled by a puzzling spike in colorectal cancer among people in their 20s, 30s, and 40s. A new MSK effort aims to help them cope — and find out what’s going on.

MSK colorectal cancer patient Katie Rich with her familly

Q&A

The Latest on Genetic Testing for BRCA Mutations in Breast Cancer

An MSK medical oncologist and geneticist discusses the latest drug approved for breast cancer and how genetic testing can lead to new treatments.

Molecular model of olaparib